CD14+-Monocytes Exposed to Apolipoprotein CIII Express Tissue Factor
International Journal of Molecular Sciences · 22.01.2023 · 24 (3) · 2223
DOI: 10.3390/ijms24032223 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.01.2023. Verfasst von Oliviero Olivieri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Internal Medicine, Department of Medicine, University of Verona, 37134 Verona, Italy. Hauptthemen laut MEDLINE: Monocytes, Thromboplastin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Ministry of Education, Universities and Research, Fondazione Cariverona.
Abstract (Originalsprache)
Apolipoprotein CIII (ApoCIII) represents a key regulator of plasma lipid metabolism and a recognized risk factor for atherosclerosis and cardiovascular diseases. Beyond the regulation of lipoprotein trafficking, ApoCIII is also involved in endothelial dysfunction and monocyte recruitment related to atherothrombosis. With tissue factor (TF) being the primary initiator of the blood coagulation cascade, we hypothesized that ApoCIII-treated monocytes could express it. Hence, human CD14+-monocytes and autologous neutrophils were incubated with ApoCIII and sera from human subjects containing previously measured ApoCIII amounts. By RT-qPCR and ELISA, CD14+-monocytes, but not neutrophils, were found to show increased mRNA expression and production of TNFα, IL-1β and IL-6 as well as TF mRNA once exposed to ultra-purified ApoCIII. By flow cytometry, CD14+-monocytes were found to rapidly express TF on their cell surface membrane when incubated with either ApoCIII or sera with known concentrations of ApoCIII. Finally, preincubation with specific ApoCIII-neutralizing antibodies significantly reduced the ability of most sera with known concentrations of ApoCIII to upregulate TF protein, other than partially inhibiting cytokine release, in CD14+-monocytes. In sum, herein we demonstrate that ApoCIII activates CD14+-monocytes to express TF. The data identify a potential mechanism which links circulating apolipoproteins with inflammation and atherothrombosis-related processes underlying cardiovascular risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Internal Medicine, Department of Medicine, University of Verona, 37134 Verona, Italy.
- Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.
ORCID-Profile: Oliviero Olivieri, Elisa Gardiman, Nicola Martinelli, Nicola Tamassia
Förderung
- Italian Association for Cancer Research
- Ministry of Education, Universities and Research
- Fondazione Cariverona
- AIRC
- MIUR-PRIN
Zitieren
APA
Olivieri, O., Gasperini, S., Calzetti, F., Gardiman, E., Castagna, A., Martinelli, N., Tamassia, N., & Cassatella, M. A. (2023). CD14+-Monocytes Exposed to Apolipoprotein CIII Express Tissue Factor. International Journal of Molecular Sciences, 24(3), 2223. https://doi.org/10.3390/ijms24032223
Vancouver
Olivieri O, Gasperini S, Calzetti F, Gardiman E, Castagna A, Martinelli N, et al. CD14+-Monocytes Exposed to Apolipoprotein CIII Express Tissue Factor. International Journal of Molecular Sciences. 2023;24(3):2223. doi:10.3390/ijms24032223
BibTeX
@article{Olivieri2023,
author = {Olivieri, Oliviero and Gasperini, Sara and Calzetti, Federica and Gardiman, Elisa and Castagna, Annalisa and Martinelli, Nicola and Tamassia, Nicola and Cassatella, Marco A},
title = {CD14+-Monocytes Exposed to Apolipoprotein CIII Express Tissue Factor},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2223},
doi = {10.3390/ijms24032223}
}
EUVIMED